The DOI matches its Crossref record; 490 of the 490 references it cites were found in a registry or an index.
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
Abstract
Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the patients treated since then are probably numbered in the millions. Fifty to 90% of hyperthyroid patients are cured within 1 yr after 131I therapy. With longer follow-up, permanent hypothyroidism seems inevitable in Graves' disease, whereas this risk is much lower when treating toxic nodular goiter. The side effect causing most concern is the potential induction of ophthalmopathy in predisposed individuals. The response to 131I therapy is to some extent related to the radiation dose. However, calculation of an exact thyroid dose is error-prone due to imprecise measurement of the 131I biokinetics, and the importance of internal dosimetric factors, such as the thyroid follicle size, is probably underestimated. Besides these obstacles, several potential confounders interfere with the efficacy of 131I therapy, and they may even interact mutually and counteract each other. Numerous studies have evaluated the effect of 131I therapy, but results have been conflicting due to differences in design, sample size, patient selection, and dose calculation. It seems clear that no single factor reliably predicts the outcome from 131I therapy. The individual radiosensitivity, still poorly defined and impossible to quantify, may be a major determinant of the outcome from 131I therapy. Above all, the impact of 131I therapy relies on the iodine-concentrating ability of the thyroid gland. The thyroid 131I uptake (or retention) can be stimulated in several ways, including dietary iodine restriction and use of lithium. In particular, recombinant human thyrotropin has gained interest because this compound significantly amplifies the effect of 131I therapy in patients with nontoxic nodular goiter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–490 of 490
Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
van Isselt, J. W., de Klerk, J. M. H., & Lips, C. J. M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0592-1 · Cited by 24
Riesco‐Eizaguirre, G., la Vieja, A. D., Rodrı́guez, I., Miranda, S., Martín‐Duque, P., Vassaux, G., & Santisteban, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2373 · Cited by 24
Greenlee, C. M., Burmeister, L. A., Butler, R. S., Edinboro, C. H., Morrison, S., & Milas, M. (2011) · Thyroid · doi:10.1089/thy.2010.0090 · Cited by 24
Andrade, V. A., Gross, J., & Maia, A. L. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510467 · Cited by 24
Mühlbauer, M., da Silva, A. C. M., Marassi, M. P., Lourenço, A. L., Ferreira, A. C. F., & de Carvalho, D. P. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0421 · Cited by 24
Gamstedt, A., & KARLSSON, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-125 · Cited by 24
Rafferty, B., & Das, R. G. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2207 · Cited by 24
Berg, G. E. B., Andersson, T., Sjödell, L., Jansson, S. K. G., & Nyström, E. (2005) · Thyroid · doi:10.1089/thy.2005.15.1389 · Cited by 23
Romão, R., Rubio, I. G. S., Tomimori, E. K., Camargo, R. Y. A., Knobel, M., & Medeiros-Neto, G. A. (2009) · Thyroid · doi:10.1089/thy.2008.0394 · Cited by 23
Decreased salivary gland function in patients with autoimmune thyroiditis
Chang, C., Shiau, Y., Wang, J.-J., Ho, S., & Kao, C. (2002) · Head & Neck · doi:10.1002/hed.10192 · Cited by 23
Regalbuto, C., Alagona, C., Maiorana, R., Paola, R. D., Cianci, M., Alagona, G., Sapienza, S., Vigneri, R., & PEZZINO, V. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349174 · Cited by 23
Esfahani, A. F., Kakhki, V. R. D., Fallahi, B., Eftekhari, M., Beiki, D., Saghari, M., & Takavar, A. (2005) · PubMed · Cited by 22
Morsch, E. P., Vanacor, R., Furlanetto, T. W., & Schmid, H. (2010) · Thyroid · doi:10.1089/thy.2010.0232 · Cited by 22
Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism
Aro, A., Huttunen, J. K., Lamberg, B. ‐., et al. (1981) · European Journal of Endocrinology · doi:10.1530/acta.0.0960321 · Cited by 22
Bonnema, S. J., Nielsen, V. E., & Hegedűs, L. D. (2006) · Acta Oncologica · doi:10.1080/02841860600617084 · Cited by 22
Self-citationEnhancement of Vascular Endothelial Function by Recombinant Human Thyrotropin
Napoli, R., Biondi, B., Guardasole, V., D’Anna, C., Sena, A. D., Pirozzi, C., Terracciano, D., Mazzarella, C., Matarazzo, M., & Saccà, L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2797 · Cited by 22
Chen, D. Y., Schneider, P. F., Zhang, X. S., He, Z. M., Jin, J., & Chen, T. H. (2011) · Thyroid · doi:10.1089/thy.2010.0348 · Cited by 22
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines
Fröhlich, E., Brossart, P., & Wahl, R. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1024-6 · Cited by 22
Reinhardt, M. J., Biermann, K., Wissmeyer, M., Juengling, F. D., Brockmann, H., von Mallek, D., Ezziddin, S., Joe, A., & Krause, T. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0051-9 · Cited by 22
KAISE, K., KAISE, N., Yoshida, K., et al. (1991) · Endocrinologia Japonica · doi:10.1507/endocrj1954.38.429 · Cited by 21
Albino, C. C., Graf, H., Paz-Filho, G., DIEHL, L. A., Olandoski, M., Sabbag, A. F. F., & Buchpiguel, C. A. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500001 · Cited by 21
Ceccarelli, C., Antonangeli, L., Brozzi, F., Bianchi, F., Tonacchera, M., Santini, P., Mazzeo, S., Bencivelli, W., Pinchera, A., & Vitti, P. (2011) · Thyroid · doi:10.1089/thy.2010.0088 · Cited by 21
Elias, A. N., & Lizotte, P. E. (2006) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000233148.45744.44 · Cited by 21
Performance of a third‐generation TSH‐receptor antibody in a UK clinic
Theodoraki, A., Jones, G., Parker, J. C., Woolman, E., Martin, N. G., Perera, S., Thomas, M., Bunn, C. F., Khoo, B. C. E., Bouloux, P. M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04022.x · Cited by 21
Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication
Ghadban, W. K., Zirie, M. A., Al-Khateeb, D. A., Jayyousi, A., Mobayed, H., & El-Aloosy, A. S. (2003) · Saudi Medical Journal · doi:10.15537/1658-3175.2007 · Cited by 21
Prevention of DNA Double-Strand Breaks Induced by Radioiodide-131I in FRTL-5 Thyroid Cells
Hershman, J. M., Okunyan, A., Rivina, Y., Cannon, S. M., & Hogen, V. (2010) · Endocrinology · doi:10.1210/en.2010-1163 · Cited by 21
Giusti, M., Cappi, C., Santaniello, B., Ceresola, E., Augeri, C., Lagasio, C., & Minuto, F. M. (2006) · PubMed · Cited by 21
Meller, B., Gáspár, E., Deisting, W., Czarnocka, B., Baehre, M., & Wenzel, B. E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0666-0 · Cited by 21
Morris, L. F., Waxman, A. D., & Braunstein, G. D. (2000) · Thyroid · doi:10.1089/thy.2000.10.779 · Cited by 20
Nakazato, N., Yoshida, K., Mori, K., KISO, Y., SAYAMA, N., Tani, J., Nakagawa, Y., & Ito, S. (1999) · Thyroid · doi:10.1089/thy.1999.9.775 · Cited by 20
Calegaro, J. U. M., De Freitas Gomes, E., Sh, B., Ulyssea, R., & Casulari, L. A. (2000) · PubMed · Cited by 20
Kristoffersen, U. S., Hesse, B., Rasmussen, Å. K., & Kjær, A. (2006) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2006.00666.x · Cited by 19
Thyroid volume and function after 131I treatment of diffuse non‐toxic goitre
Nygaard, B., Faber, J. O., Veje, A., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1760987.x · Cited by 19
Recombinant Human Thyrotropin Stimulates Thyroid Angiogenesis In Vivo
Klein, M., Brunaud, L., Mureşan, M., Barbé, F., Marie, B., Sapin, R., Vignaud, J.-M., Chatelin, J., Angioï-Duprez, K., Zarnegar, R., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.531 · Cited by 19
Radioiodine for non-toxic diffuse goitre
Hegedűs, L. D., & Bennedbæk, F. N. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64132-3 · Cited by 18
Self-citationRecombinant Human Thyrotropin Enhances Endothelial-Mediated Vasodilation of Conduit Arteries
Napoli, R., Apuzzi, V., Bosso, G., D’Anna, C., Sena, A. D., Pirozzi, C., Marano, A., Lupoli, G., Cudemo, G., Oliviero, U., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2298 · Cited by 18
Carlier, T., Salaün, P., Cavarec, M.-B., Valette, F., Turzo, A., Bardiès, M., Bizais, Y., & Couturier, O. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200607000-00003 · Cited by 17
Serum TSH and the response to radioiodine treatment of toxic multinodular goitre
Pedersen‐Bjergaard, U., & KIRKEGAARD, C. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370365 · Cited by 17
Üstün, F., Yüksel, M., Dukmus-Altun, G., Kaya, M., Çermjk, T. F., Sarıkaya, A., & Berkarda, Ş. (2005) · Annals of Nuclear Medicine · doi:10.1007/bf02985126 · Cited by 17
McCormack, S. E., Mitchell, D. M., Woo, M., Levitsky, L. L., Ross, D. S., & Misra, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03565.x · Cited by 16
Chiappori, A., Villalta, D., Bossert, I., Ceresola, E., Lanaro, D., Schiavo, M., Bagnasco, M., & Pesce, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346581 · Cited by 16
Walter, M. A., Schindler, C., Christ‐Crain, M., Müller‐Brand, J., & Müller-Stich, B. P. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02061.x · Cited by 16
Clinical Course of Pediatric and Adolescent Graves' Disease Treated with Radioactive Iodine
Pinto, T. E., Cummings, E. A., Barnes, D., & Salisbury, S. R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.9.973 · Cited by 16
Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma
Ish‐Shalom, S., Durleshter, L., Segal, E., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0634 · Cited by 16
Turton, D. B., SILVERMAN, E. D., & Shakir, K. M. M. (1998) · Clinical Nuclear Medicine · doi:10.1097/00003072-199812000-00004 · Cited by 16
Reinfelder, J., Maschauer, S., Foss, C. A., Nimmagadda, S., Frémont, V., Wolf, V., Weintraub, B. D., Pomper, M. G., Szkudlinski, M. W., Kuwert, T., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0394 · Cited by 15
Paz-Filho, G., Mesa, C. O., de Carvalho, G. A., Goedert, C. A., & Graf, H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03165.x · Cited by 15
Discriminant factors affecting early outcome of radioiodine treatment for graves' disease
Kung, A. W. C., Choi, P., Lam, K. S. L., Pun, K. K., Wang, C.-L., & YEUNG, R. T. T. (1990) · Clinical Radiology · doi:10.1016/s0009-9260(05)81624-1 · Cited by 15
Barca, M. F., Gruppi, C. J., de Oliveira, M. T., Romão, R., Cardia, M., Rubio, I. G. S., Knobel, M., & Medeiros-Neto, G. A. (2007) · Endocrine · doi:10.1007/s12020-007-9020-3 · Cited by 15
Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium
Vannucchi, G. M., Chiti, A., Mannavola, D., Dazzi, D., Rodari, M., Tadayyon, S., Beck‐Peccoz, P., & Fugazzola, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1818-8 · Cited by 15
Desideri, G., Bocale, R., Milardi, D., Ghiadoni, L., Grassi, D., Necozione, S., Taddei, S., di Orio, F., Pontecorvi, A., & Ferri, C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03485.x · Cited by 15
Traino, C., Grosso, M., & Mariani, G. (2009) · Physica Medica · doi:10.1016/j.ejmp.2009.08.003 · Cited by 14
Custro, N., Ganci, A., & Scafidi, V. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345136 · Cited by 14
Hautzel, H., Pisar, E., Yazdan-Doust, N., Schott, M., Beu, M., & Müller, H. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.080473 · Cited by 14
Traino, C., & Xhafa, B. (2009) · Medical Physics · doi:10.1118/1.3093237 · Cited by 14
ZANZONICO, P. B., Becker, D. V., & Hurley, J. R. (2004) · PubMed · Cited by 14
EUGOGO, Lazarus, J. H., Bartalena, L., Marcocci, C., Kahaly, G. J., Krassas, G. E., & Wiersinga, W. M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346613 · Cited by 13
Historical Background of the Use of Radioactive Iodine in Medicine
Means, J. H. (1955) · New England Journal of Medicine · doi:10.1056/nejm195506022522204 · Cited by 13
Galleani, J., Miranda, C., Pierotti, M. A., & Greco, A. (2009) · Thyroid · doi:10.1089/thy.2008.0195 · Cited by 13
Recombinant human thyrotropin in the management of thyroid disorders
Paz-Filho, G., & Graf, H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1721 · Cited by 13
Outcome of treatment of hyperthyroidism
Bringmann, I. M., van Leeuwen, B. L., Hennemann, G., Beckett, G. J., & Toft, A. D. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343552 · Cited by 12
Reinartz, P., Zimny, M., Schaefer, W. M., MUELLER, B., Buell, U., & Sabri, O. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200312000-00008 · Cited by 12
Zanotti‐Fregonara, P., Duron, F., Keller, I., et al. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32804c58c2 · Cited by 12
Giusti, M., Caputo, M., Calamia, I., Bagnara, M. C., Ceresola, E., Schiavo, M., Mussap, M., Ferone, D., Minuto, F. M., & Bagnasco, M. (2009) · Thyroid Research · doi:10.1186/1756-6614-2-6 · Cited by 12
Walter, M. A., Christ‐Crain, M., Müller, B., & Müller‐Brand, J. (2005) · PubMed · doi:10.1267/nukl05010033 · Cited by 12
Shi, G.-M., Xu, Q., Zhu, C.-Y., & Yang, Y.-L. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700235 · Cited by 11
A randomized trial evaluating a block-replacement regimen during radioiodine therapy
Bonnema, S. J., Grupe, P., Boel-Jørgensen, H., Brix, T. H., & Hegedűs, L. D. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02452.x · Cited by 10
Self-citationBiondi, B., Palmieri, E. A., Pagano, L., Klain, M., Scherillo, G., Salvatore, M., Fenzi, G., Lombardi, G., & Fazio, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020544 · Cited by 10
Kung, A. W. C., Pun, K. K., Lam, K. S. L., CHOI, P., Wang, C., & YEUNG, R. T. T. (1990) · QJM · doi:10.1093/oxfordjournals.qjmed.a068498 · Cited by 10
Dederichs, B., Otte, R., Klink, J. E., & Schicha, H. (1996) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1629802 · Cited by 10
Sabri, O., Zimny, M., Schreckenberger, M., et al. (2001) · PubMed · Cited by 10
Schneider, P., Biko, J., Hänscheid, H., Hilliger, S., Koutsampelas, C., Kranzfelder, M., Ladner, S., & Reiners, C. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1769-0 · Cited by 9
Nygaard, B., Jarløv, A., Kristensen, L. Ø., & Faber, J. O. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978637 · Cited by 9
Influence of iodine application during radioiodine therapy in case of impending therapy failure
Urbannek, V., Schmidt, M. C., Moka, D., Hillger, H. W., Voth, E., Wellner, U., & Schicha, H. (2000) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1632255 · Cited by 9
Characterization of radioiodine therapy failures in Graves’ disease
Zimny, M., Schreckenberger, M., Reinartz, P., et al. (2001) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1623985 · Cited by 9
Refaei, S. M., & Shawkat, W. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282fda205 · Cited by 8
Upper airway obstruction due to goiter
Bonnema, S. J. (2008) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.40769 · Cited by 8
Self-citationEffects of Acute Recombinant Human TSH on Serum Ghrelin Levels
Ciuoli, C., Brusco, L., Theodoropoulou, A., Castagna, M. G., Neri, O., Pasqui, L., & Pacini, F. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00094 · Cited by 8
Bonnema, S. J., Fast, S., Nielsen, V. E., Boel-Jørgensen, H., Grupe, P., Andersen, P. B., & Hegedűs, L. D. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347076 · Cited by 8
Self-citationTransient hypothyroidism after iodine-131 treatment of Graves' disease.
Jm, G. S., Virgili, N. M., Soler, J., Fernández, M., & Montaña, E. (1989) · PubMed · Cited by 8
Vickers, P. M., Garg, K., Arya, R., Godha, U., Mathur, P., & Jain, S. (1990) · PubMed · Cited by 8
Bazzi, M. N., & Bagchi, N. (1993) · Thyroid · doi:10.1089/thy.1993.3.269 · Cited by 7
Use of Cold Iodine in Patients With Graves’ Disease: Observations From a Clinical Practice
Hao, S. T., Reasner, C. A., & Becker, R. A. (2001) · Endocrine Practice · doi:10.4158/ep.7.6.438 · Cited by 7
Savastano, S., Pivonello, R., Acampa, W., Salvatore, M., Lombardi, G., Colao, A., & Fenzi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2135 · Cited by 6
Lee, S., Lee, J., Bae, J.-H., Seo, J.-H., Kang, S.-M., Ahn, B., & Lee, I. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328324b447 · Cited by 6
Gamstedt, A., Järnerot, G., Kågedal, B., et al. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02757.x · Cited by 5
Sun, J.-C., Huang, H.-C., Huang, M. J., Huang, B., Lin, J., Hsu, B.-K., Chiou, S. C., & Lo, S. K. (1995) · PubMed · Cited by 5
Immunological effects of Graves' disease therapy
Weetman, A. P. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90037-1 · Cited by 3
Cm, K., Magdam, M., Ravishankar, L., Dham, D. N., & Chugh, P. (1995) · PubMed · Cited by 2
Prinsen, A. K. E., Jansen, J., Bakker, W. H., & Wildschut, H. I. J. (2006) · PubMed · Cited by 1
Cited by
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
Self-citation2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 940
Self-citationDe Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationClinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237
Metadata
- Authors
- Bonnema, S. J., & Hegedüs, L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-09-07
- Volume
- 33
- Issue
- 6
- Pages
- 920-980
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2126241583
- Cited by
- 339
- References
- 490
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.